PALMISANO ROBERT J (CEO) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/22/2026ACC: 0001104659-26-076513
DirectorOfficer10% Owner· CEO
Since Feb 2021
+222.68K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
222.68K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+222.68K
Price / share
—
Trade value
—
% of position
618.2%
6/17/2026
36.02K→258.70K
Total
Net shares
+222.68K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/17/2026 | A · Award | +222.68K | — | — | 618.2% | 36.02K | 258.70K |
| Total | +222.68K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported